• On June 23, 2016, the UK electorate voted in a referendum to voluntarily depart from the EU, known as "Brexit".The Trade and Cooperation Agreement ("TCA") was signed on December 30, 2020.These factors include, but are not limited to: changes to income tax rates, to tax laws or the interpretation of such tax laws (including additional proposals for fundamental international tax reform globally); the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards, treatment or characterization of intercompany transactions, changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in U. S. generally accepted accounting principles; expiration or the inability to renew tax rulings or tax holiday incentives; and divestitures of current operations.The agreements governing our New Senior Secured Credit Facilities (as defined below) impose material operating and financial restrictions that limit our operating flexibility, including the following: • The Credit Agreement (as defined below) governing our New Senior Secured Credit Facilities contain, and agreements governing our other indebtedness may contain, a number of restrictions and covenants that, among other things, limit our ability and/or our restricted subsidiaries’ ability to: • incur or assume liens or additional debt or provide guarantees in respect of obligations of other persons; • pay dividends or distributions or redeem or repurchase capital stock; • prepay, redeem or repurchase certain debt; 32 Perrigo Company plc-Item 1 ARisk Factors • make loans, investments, acquisitions (including certain acquisitions of exclusive licenses) and capital expenditures; • enter into agreements that restrict distributions from our subsidiaries; • enter into transactions with affiliates; • enter into sale and lease-back transactions; • sell, transfer or exclusively license certain assets, including material intellectual property, and capital stock of our subsidiaries; and • consolidate or merge with or into, or sell substantially all of our assets to, another person.As an Irish company, we are governed by the Irish Companies Act 2014 (the "Act").A number of factors may limit our ability to pay dividends, including, among other things: • Our ability to receive cash dividends and distributions from our subsidiaries; • Compliance with applicable laws and debt covenants; • Our financial condition, results of operations, capital requirements, general business conditions, and other factors that our Board of Directors may deem relevant; and • The availability of our distributable reserves, being profits of the company available for distribution to shareholders.Alternatively, issuing equity to pay all or a portion of acquisition purchase price would dilute our existing shareholders.Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations.• Under Irish law, the duties of directors and officers of a company are generally owed to the company only.The UK now has an ability to diverge from EU regulation (the UK Government’ s stated aim), which could enable the UK to seek competitive regulatory advantage.On May 2, 2017, we disclosed that search warrants were executed at several Perrigo facilities and other locations in connection with the Antitrust Division’ s ongoing investigation related to drug pricing in the pharmaceutical industry.An incremental six months of contract manufacturing sales to the divested Rx business, which closed on July 6, 2021, also contributed $62.0 million of net sales.We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.40 Perrigo Company plc-Item 7 ConsolidatedCONSOLIDATED Consolidated Financial ResultsNet sales increased $312.9 million, or 7.6%, due to: • $354.8 million increase, or 8.8%, due primarily to $155.9 million in strategic pricing actions and $140.5 million stemming from global category growth and U. S. store brand market share gains resulting in higher net sales across several Perrigo global product categories.44 Perrigo Company plc-Item 7 CSCIOperating income decreased $66.1 million, or 183.1%, due to: • $17.1 million increase in gross profit due primarily to strategic price increases, higher gross profit flow-through resulting from net sales growth, and $70.0 million from the addition of HRA Pharma, partially offset by unfavorable foreign currency translation excluding acquisitions and the impact of inflation.We perform annual goodwill impairment testing on the first day of the fourth quarter.Gross profit as a percentage of net sales decreased 210 basis points compared to the prior year due to inflation, lower productivity, and the addition of third party sales to the divested Rx business, which have a lower margin profile.Gross profit as a percentage of net sales decreased 120 basis points due to lost market share on higher margin products offset by the addition of HRA Pharma; which was more than offset by • $83.2 million increase in operating expenses due primarily to $113.6 from the addition of HRA Pharma and higher employee expenses, partially offset by $62.1 million from foreign currency translation excluding acquisitions.We also received $417.6 million in September 2021 relating to the claim arising from the 2015 Omega Acquisition.Credit Ratings The interest of the 3.150% Senior Notes due 2030 stepped up from 3.900% to 4.400% on payments made after June 15, 2022 due to a credit ratings downgrade by S & P Global Ratings and Moody’ s Investor Services in the first quarter of 2022.Guarantor Financial Information The Guarantor Subsidiaries and the Borrower provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Loan Parties provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Investments, LLC. The guarantees of the Guarantor Subsidiaries, the Company and the Borrower are subject to release in limited circumstances only upon the occurrence of certain customary conditions.If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter.